Have a personal or library account? Click to login
The role of pumpkin pulp extract carotenoids against mycotoxin damage in the blood brain barrier in vitro Cover

The role of pumpkin pulp extract carotenoids against mycotoxin damage in the blood brain barrier in vitro

Open Access
|Sep 2021

Figures & Tables

Figure 1

Workflow used to assess the metabolic profile of the blood-brain barrier model exposed to mycotoxins with and without pumpkin extract. BBB – blood brain barrier; LC-ESI-QTOF-MS – liquid chromatography-electrospray ionisation quantitative time of flight-mass spectrometry
Workflow used to assess the metabolic profile of the blood-brain barrier model exposed to mycotoxins with and without pumpkin extract. BBB – blood brain barrier; LC-ESI-QTOF-MS – liquid chromatography-electrospray ionisation quantitative time of flight-mass spectrometry

Figure 2

Venn diagrams of the number of significant metabolites (p<0.05) after 2-hour mycotoxin exposure (100 nmol/L per mycotoxin) without pumpkin extract (A) and with pumpkin extract (500 nmol/L) (B)
Venn diagrams of the number of significant metabolites (p<0.05) after 2-hour mycotoxin exposure (100 nmol/L per mycotoxin) without pumpkin extract (A) and with pumpkin extract (500 nmol/L) (B)

Log2FC values of metabolites with significantly changed quantity (p<0_05) compared to respective controls (control containing vehicle or vehicle + pumpkin extract) found in the basal media after 2-hour exposure to mycotoxins (100 nmol/L each) with or without pumpkin extract (500 nmol/L beta-carotene equivalent)

CompoundBEABEA+EOTAOTA+EZEAZEA+EOTA+ZEAOTA+ZEA+EBEA+OTA+ZEABEA+OTA+ZEA+E
(2R,3S,7S,10S)-2,3,7,10-tetramethyl dodecahydrocyclo 15.57 penta[b]quinolizin-2-ol
(5E)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / (5E)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide 15.68
12-epi leukotriene B4-d418.12
12,13-DiHOME-d418.35 18.49 18.34
14,15-LTE4 15.56 15.56 15.56
2-(3-phenylpropyl)pyridine 20.60 19.28 17.84
2-butyl-5-methyl-4-propyloxazole15.70 15.49 15.79 15.9815.88
2-ethyl-5-methylpyridine 19.36
23--(propenal, 1,3-benzodioxol-5-yl)--19.1518.18-19.1516.59 17.06 1.96-19.151.87
2glucinolcarboxylate -protocatechoylphloro -16.29 -16.29 -16.29
2,6-dihydroxy-4-methoxytoluene 2.06
3-methylfluoranthene 16.09
3-methylxanthine 16.28
3,4-dichlorophenol-17.93 -17.93 -17.93 -17.93
4-(3-hydroxy-7-phenyl-6-heptenyl)-1,2-benzenediol 17.37
6-hydroxy-4-decanolide 16.7716.37
67--hydroxykaempferol rutinoside -16.32 17.04 17.18 -16.32
6'-hydroxy-2,3,4,5,2',3',4'-heptamethoxychalcone17.06
9-docosene 16.35 16.9416.6316.6516.5816.33 16.38
Asp-Met-OH 16.18 16.80
(7R)-7,15,17-trihydroxy-11-methyl-octadeca-121-oxabicyclo[(14),15,17-trien- 12.4.0] 13-one -17.71 -17.71 -17.71 -17.71 -1.68
Dihydromorelloflavone -16.68 -16.18 -16.18 -16.18 -16.18
Dimethylmaleic anhydride acid 17.6118.0416.0617.80 17.122.0517.751.92
Dodemorph -16.9818.23-16.98-16.82-16.98 16.30 16.16
Herbacetin 8-(2'',3'',4''-triacetylxyloside) 15.76
Hexazinone -18.83-16.76 -16.76 -18.83
Ketophenylbutazone 17.33 17.17
Mercaptoethanol 16.4619.32-19.14
Methylmethionine sulfonium 0.73
N-(ethyl) 2'-(4arachidonoyl -benzenesulfonamide)- amine21.5621.2819.63 16.4617.65 21.39
N-(2'-(4-benzenesulfonamide)-ethyl) arachidonoyl amine 17.2917.69 18.54
Nigrifactin 18.2218.52
Oleamide 16.96
Oleic acid(d2) 15.34
Peroxyoctanoic acid 1.53
PG(16:0/0:0)-17.39-17.11-17.39-17.11 -17.11-17.39-17.11-17.39-17.11
Pregna-4,16-diene-3,11,20-trione 17.12
Propyl levulinate 17.22
Prostaglandin D2-1-glyceryl ester 17.60 18.09
Prostaglandin D2-1-glyceryl
ester
Rhamnetin 3-rhamnoside 16.60 17.31 16.07
Spiromesifen 16.13 16.45
Streptonigrin 16.70 16.51
Tioconazole 19.47
Vestitone 7-glucoside 17.07 17.05
Xestoaminol C-16.08-16.70-16.08 16.50 -16.72 -16.70
DOI: https://doi.org/10.2478/aiht-2021-72-3541 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 173 - 181
Submitted on: Feb 1, 2021
Accepted on: Aug 1, 2021
Published on: Sep 28, 2021
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Manuel Alonso-Garrido, Noelia Pallarés, Guillermina Font, Paola Tedeschi, Lara Manyes, Manuel Lozano, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.